Boston Scientific Corp. Stock Slides 5.9%, Underperforms Peers
Dow Jones2026/09/08 20:34This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Boston Scientific Corp. slipped 5.9% to $44.98 on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.6% to 7,673.52 and Dow Jones Industrial Average falling 1.2% to 52,786.07.
Boston Scientific Corp. closed 58.9% below its 52-week high of $109.50, which the company achieved on September 9th.
The stock demonstrated a mixed performance when compared to some of its peers, as Abbott Laboratories fell 2.6% to $105.52, Medtronic PLC fell 1.9% to $92.39, and Stryker Corp. fell 8.81% to $276.43.
Trading volume totaled 29.0 million, compared to the 50-day average of 20.0 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 08, 2026 16:34 ET (20:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
ASBIS posts August revenue up 91% to USD 604 million, sets monthly record
The new Roadster, postponed for nine years, finally has a release date! Morningstar maintains Tesla (TSLA.US) target price at $450: Supercars are not the valuation logic, FSD, Robotaxi, and Optimus are.
Tesla has officially announced that the new generation Roadster will be unveiled on October 1. However, institutions generally believe that this is primarily a branding campaign and will have minimal impact on the company's valuation.
Market Chatter: Paramount, California Settlement Talks Include Penalty for Missing 30-Film Pledge
Intesa Sanpaolo hosts Italian Equity Champions investor conference in New York
Crypto prices
More
